id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2004-E-0270-0010,FDA,FDA-2004-E-0270,U.S. Patent and Trademark Office to Connolly Bove Lodge & Hutz LLC - Letter,Other,LET-Letter,2011-05-12T04:00:00Z,2011,5,2011-05-12T04:00:00Z,,2011-05-12T16:31:51Z,,0,0,0900006480c75b63
FDA-2004-E-0270-0009,FDA,FDA-2004-E-0270,Notice of Determination and Requirement for Election,Other,LET-Letter,2010-12-23T05:00:00Z,2010,12,,,2010-12-27T17:55:37Z,,0,0,0900006480bbec80
FDA-2004-E-0270-0008,FDA,FDA-2004-E-0270,FDA/CDER to US Patent and Trademark Office - Letter,Other,LET-Letter,2010-03-04T05:00:00Z,2010,3,2010-03-04T05:00:00Z,,2013-07-27T23:10:39Z,,0,0,0900006480ab4181
FDA-2004-E-0270-0007,FDA,FDA-2004-E-0270,Determination of Regulatory Review Period for Purposes of Patent Extension; SENSIPAR,Notice,N-Notice,2009-05-14T04:00:00Z,2009,5,2009-05-14T04:00:00Z,2009-07-14T03:59:59Z,2009-05-15T07:34:10Z,E9-11219,0,0,0900006480991e92
FDA-2004-E-0270-0006,FDA,FDA-2004-E-0270,FDA/CDER to US Patent and Trademark Office -  Letter,Other,LET-Letter,2009-04-28T04:00:00Z,2009,4,2009-04-28T04:00:00Z,,2009-04-28T18:34:06Z,,0,0,090000648096de01
FDA-2004-E-0270-0005,FDA,FDA-2004-E-0270,Duplicate - Application for Patent Term Extension from NPS Pharmaceuticals Inc.,Other,Application,2009-04-28T04:00:00Z,2009,4,2009-04-28T04:00:00Z,,2025-11-18T21:18:05Z,,0,0,0900006480472212
FDA-2004-E-0270-0003,FDA,FDA-2004-E-0270,Letter from U.S. Patent and Trademark Office to FDA CDER,Other,Letter(s),2008-10-23T04:00:00Z,2008,10,2008-10-23T04:00:00Z,,2025-11-18T21:11:52Z,,0,0,09000064807747d9
FDA-2004-E-0270-0004,FDA,FDA-2004-E-0270,Application for Patent Term Extension from NPS Pharmaceuticals Inc.,Other,Application,2008-10-23T04:00:00Z,2008,10,,,2025-11-18T21:15:21Z,,0,0,0900006480472213
FDA-2004-E-0270-0002,FDA,FDA-2004-E-0270,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2004-10-22T04:00:00Z,2004,10,,,2025-11-18T20:55:15Z,,0,0,0900006480472217
FDA-2004-E-0270-0001,FDA,FDA-2004-E-0270,Letter from U.S. Patent & Trademark Office to FDA CDER,Other,Letter(s),2004-09-01T04:00:00Z,2004,9,,,2025-11-18T20:43:55Z,,0,0,0900006480472211